BCPC
Balchem Corporation NASDAQ Listed Jun 3, 1986$165.92
+0.94%
vs $164.38
Mkt Cap $5.3B
52w Low $139.17
59.8% of range
52w High $183.90
50d MA $165.25
200d MA $161.76
P/E (TTM)
34.9x
EV/EBITDA
21.7x
P/B
4.3x
Debt/Equity
0.1x
ROE
3.1%
P/FCF
31.3x
RSI (14)
74.80
ATR (14)
$3.10
Beta
0.95
50d MA
$165.25
200d MA
$161.76
Avg Volume
199.6K
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
52 Sunrise Park Road · Montvale, NY 10958 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | BMO | 1.29 | 1.31 | +1.6% | 175.00 | -0.3% | -2.1% | +2.6% | +1.6% | +0.6% | +0.4% | — |
| Oct 21, 2025 | BMO | 1.36 | 1.35 | -0.7% | 150.77 | +0.3% | +4.1% | +0.1% | -0.2% | -0.1% | -1.4% | — |
| Jul 31, 2025 | BMO | 1.25 | 1.27 | +1.6% | 152.09 | -1.4% | +0.2% | -0.2% | +2.1% | +0.7% | +2.3% | — |
| Apr 24, 2025 | BMO | 1.25 | 1.22 | -2.4% | 158.31 | -1.3% | -2.6% | -0.4% | +1.6% | -0.1% | +0.3% | — |
| Feb 21, 2025 | BMO | 1.11 | 1.03 | -7.2% | 161.34 | +3.5% | +1.5% | +1.1% | +4.8% | -0.5% | -0.4% | — |
| Oct 25, 2024 | BMO | 1.11 | 1.13 | +1.8% | 166.16 | +9.6% | +3.2% | -0.4% | -0.9% | -0.2% | -0.9% | — |
| Jul 26, 2024 | BMO | 1.03 | 1.09 | +5.8% | 174.81 | +2.1% | +3.4% | +0.4% | -1.9% | -0.4% | -0.8% | — |
| May 3, 2024 | BMO | 0.98 | 1.03 | +5.1% | 146.28 | +0.5% | +2.8% | +1.9% | +1.4% | -1.4% | +1.1% | — |
| Feb 16, 2024 | BMO | 0.93 | 0.95 | +2.2% | 146.39 | +1.1% | +1.9% | +5.4% | -2.3% | +1.1% | +1.0% | — |
| Oct 27, 2023 | BMO | 0.97 | 1.04 | +7.2% | 121.68 | -5.5% | -5.4% | +0.4% | +0.6% | +0.4% | +1.9% | — |
| Jul 28, 2023 | BMO | 0.84 | 1.06 | +26.2% | 128.54 | +0.8% | +1.8% | +3.0% | -1.1% | +1.3% | -0.7% | — |
| Apr 28, 2023 | BMO | 0.78 | 0.70 | -10.3% | 126.29 | +1.8% | +4.0% | -0.3% | -0.4% | +0.1% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $175.68 | $175.00 | -0.4% | +1.6% | +0.6% | +0.4% | +0.6% | +1.0% |
| Oct 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $156.89 | $157.83 | +0.6% | +0.1% | -0.2% | -0.1% | -1.4% | +0.4% |
| Aug 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $152.17 | $153.04 | +0.6% | +2.1% | +0.7% | +2.3% | -0.3% | -0.1% |
| Apr 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $153.64 | $153.93 | +0.2% | +1.6% | -0.1% | +0.3% | +0.2% | +3.2% |
| Feb 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $163.73 | $163.48 | -0.2% | +1.1% | +4.8% | -0.5% | -0.4% | +1.2% |
| Nov 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $171.46 | $171.50 | +0.0% | +0.6% | +1.6% | +4.6% | -3.7% | +1.5% |
| Jul 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $178.16 | $176.42 | -1.0% | -0.4% | -0.8% | -2.6% | -4.2% | +0.5% |
| May 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $150.40 | $152.00 | +1.1% | +1.9% | +1.4% | -1.4% | +1.1% | +0.9% |
| Feb 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $149.20 | $148.46 | -0.5% | +5.4% | -2.3% | +1.1% | +1.0% | -0.9% |
| Oct 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $115.08 | $114.74 | -0.3% | +0.4% | +0.6% | +0.4% | +1.9% | +1.8% |
| Jul 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $130.85 | $131.68 | +0.6% | +3.0% | -1.1% | +1.3% | -0.7% | +0.3% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $132.82 | $131.63 | -0.9% | -2.8% | +2.3% | +2.6% | -0.8% | -0.7% |
| Feb 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $131.76 | $131.62 | -0.1% | -1.1% | -0.2% | +2.1% | -1.1% | +1.2% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $137.13 | $138.00 | +0.6% | -3.0% | +0.4% | -0.2% | +6.3% | -0.4% |
| Aug 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $138.00 | $138.40 | +0.3% | +0.7% | -1.9% | +0.6% | +3.1% | -2.5% |
| May 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $123.20 | $122.87 | -0.3% | -0.9% | +0.1% | +2.5% | -3.8% | -1.1% |
| Mar 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $134.13 | $133.24 | -0.7% | -2.2% | +3.7% | +0.0% | -1.9% | -0.3% |
| Feb 22 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $138.01 | $139.38 | +1.0% | +1.5% | -1.7% | +0.8% | +1.7% | -1.9% |
| Jan 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $158.94 | $158.59 | -0.2% | -1.3% | +0.2% | +0.7% | -1.0% | -0.8% |
| Nov 29 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $165.28 | $163.53 | -1.1% | -1.8% | -2.6% | -0.5% | +1.9% | -1.4% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $134.89 | $134.89 | +0.0% | -1.3% | -0.8% | -0.9% | +1.2% | +0.9% |
| Aug 2 | Stephens & Co. | Downgrade | Overweight → Equal Weight | — | $134.89 | $134.89 | +0.0% | -1.3% | -0.8% | -0.9% | +1.2% | +0.9% |
| Feb 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $114.55 | $120.36 | +5.1% | +6.1% | -0.7% | +1.6% | -2.1% | -0.6% |
| Feb 22 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $114.55 | $120.36 | +5.1% | +6.1% | -0.7% | +1.6% | -2.1% | -0.6% |
| Aug 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $101.73 | $102.74 | +1.0% | -1.6% | +1.6% | +0.2% | +1.5% | -0.6% |
| Jul 10 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $91.61 | $91.69 | +0.1% | +3.0% | -0.5% | +2.0% | +2.9% | +0.2% |
| May 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $87.24 | $87.09 | -0.2% | -1.8% | +0.3% | -1.2% | -0.1% | +1.3% |
| Feb 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $103.18 | $99.68 | -3.4% | -3.1% | -2.8% | -0.1% | -2.5% | -0.3% |
| May 6 | Pivotal Research | Downgrade | Buy → Hold | — | $102.75 | $100.00 | -2.7% | -2.2% | -1.2% | +0.1% | +0.6% | +0.4% |
| Oct 16 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $96.31 | $98.93 | +2.7% | +2.8% | +1.8% | -0.5% | -0.1% | -0.4% |
| Sep 25 | H.C. Wainwright | Maintains | Buy → Buy | — | $114.97 | $116.50 | +1.3% | +0.7% | -1.5% | -0.6% | -1.0% | -1.1% |
| May 7 | Vertical Group | Downgrade | Buy → Hold | — | $92.83 | $94.05 | +1.3% | +1.1% | +1.2% | -0.4% | -0.8% | -0.3% |
| May 7 | Vertical Research | Downgrade | Buy → Hold | — | $92.83 | $94.05 | +1.3% | +1.1% | +1.2% | -0.4% | -0.8% | -0.3% |
| May 7 | Pivotal Research | Upgrade | Sell → Hold | — | $92.83 | $94.05 | +1.3% | +1.1% | +1.2% | -0.4% | -0.8% | -0.3% |
| Nov 4 | Pivotal Research | Downgrade | Hold → Sell | — | $71.78 | $71.23 | -0.8% | -1.9% | -2.6% | -0.1% | +5.6% | +3.5% |
| Mar 8 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $64.98 | $63.00 | -3.0% | -9.3% | +1.6% | -1.5% | +2.4% | -2.7% |
| Feb 2 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $56.58 | $58.23 | +2.9% | +11.5% | +3.1% | -3.9% | -1.7% | +0.9% |
| Jun 24 | Pivotal Research | Downgrade | Buy → Hold | — | $63.81 | $63.62 | -0.3% | -8.4% | -0.8% | +1.1% | -4.0% | -0.9% |
| May 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $61.16 | $60.72 | -0.7% | -5.2% | +0.7% | -5.1% | +1.0% | +1.3% |
| May 30 | Piper Sandler | Maintains | Overweight → Overweight | — | $46.84 | $47.04 | +0.4% | +0.6% | +1.9% | +1.1% | -0.9% | -1.7% |
| Mar 7 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $42.96 | $42.85 | -0.3% | -2.4% | -0.0% | -0.8% | -0.0% | +0.9% |
| Feb 22 | DA Davidson | Upgrade | Underperform → Buy | — | $38.01 | $38.09 | +0.2% | +3.7% | -1.5% | +2.4% | +0.4% | +1.1% |
| Aug 1 | DA Davidson | Maintains | Underperform → Underperform | — | $33.33 | $33.40 | +0.2% | -1.8% | +1.1% | +3.5% | +2.3% | +0.5% |
No insider trades available.
8-K
Balchem Corporation -- 8-K Filing
Balchem Corporation reported strong Q4 2025 results with $263.6 million in sales and $39.2 million in net earnings, demonstrating solid profitability and cash generation for the specialty nutrition company.
Feb 20
8-K · 5.02
!!! Very High
Balchem Corporation -- 8-K 5.02: Executive Change
Balchem Corporation appointed Erin L. Gilson as Vice President effective April 1, 2026, representing internal leadership development with minimal immediate investor impact.
Feb 19
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 2,193,417 | $372M | New | Mar 2026 |
| 2 | Morgan Stanley | 1,852,324 | $284M | Added | Dec 2025 |
| 3 | Vanguard Capital Management Llc | 1,432,088 | $243M | New | Mar 2026 |
| 4 | Wasatch Advisors Lp | 1,423,424 | $241M | Added | Mar 2026 |
| 5 | Conestoga Capital Advisors, Llc | 1,251,189 | $212M | Added | Mar 2026 |
| 6 | Geneva Capital Management Llc | 846,495 | $143M | Reduced | Mar 2026 |
| 7 | Fmr Llc | 598,670 | $101M | Added | Mar 2026 |
| 8 | First Trust Advisors Lp | 453,337 | $77M | Added | Mar 2026 |
| 9 | Congress Asset Management Co | 445,813 | $76M | Added | Mar 2026 |
| 10 | Two Sigma Investments, Lp | 430,210 | $73M | Added | Mar 2026 |
| 11 | Jpmorgan Chase & Co | 426,999 | $73M | Reduced | Mar 2026 |
| 12 | Nuveen, Llc | 393,485 | $67M | Reduced | Mar 2026 |
| 13 | Northern Trust Corp | 373,984 | $63M | Added | Mar 2026 |
| 14 | Schroder Investment Management Group | 360,496 | $61M | Reduced | Mar 2026 |
| 15 | William Blair Investment Management, Llc | 315,260 | $53M | Added | Mar 2026 |
| 16 | Clearbridge Investments, Llc | 256,813 | $44M | Reduced | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 221,523 | $38M | Reduced | Mar 2026 |
| 18 | Grantham, Mayo, Van Otterloo & Co. Llc | 212,718 | $36M | Added | Mar 2026 |
| 19 | Blair William & Co/il | 203,519 | $34M | Added | Mar 2026 |
| 20 | Algert Global Llc | 187,584 | $32M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$5.33B
Enterprise Value
$5.51B
P/E (TTM)
34.93x
Forward P/E
32.11x
PEG Ratio
1.54x
P/B
4.30x
P/S
5.22x
P/FCF
31.26x
EV/EBITDA
21.66x
Shares Out
32.6M
Financials (TTM)
Revenue
$1.04B
Net Income
$154.8M
EBITDA
$254.4M
Free Cash Flow
$173.1M
Op Cash Flow
$216.6M
EPS Basic
$4.80
EPS Diluted
$4.75
EPS Forward
$5.17
Gross Margin
35.7%
Op Margin
21.1%
Net Margin
14.9%
Balance Sheet
Total Assets
$1.71B
Total Liab.
$450.1M
Total Equity
$1.26B
Cash
$74.6M
LT Debt
$175.3M
Book Value/Sh
$38.57
Debt/Equity
0.15x
Current Ratio
2.07
Quick Ratio
1.33
Returns & Growth
ROE
3.1%
ROA
2.3%
ROIC
11.1%
Rev Growth YoY
+8.8%
EPS Growth YoY
+20.9%
Price Returns
2W
-2.7%
1M
-3.0%
3M
-13.6%
6M
+0.3%
12M
-6.0%
Technicals
52W High
$183.90
52W Low
$139.17
50d MA
$165.25
200d MA
$161.76
RSI (14)
74.80
ATR (14)
$3.10
Beta
0.95
Avg Volume
200K
Dividends
Div Rate
$0.87
Div Yield
0.5%
Frequency
1
Ex-Div Date
Dec 23, 2025
Analyst Price Targets
Consensus
$162.00
High
$162.00
Low
$162.00
Median
$162.00
Data updated apr 24, 2026 8:56pm
· Source: financialmodelingprep.com